by Clinical Neuropsychologist Online | Wednesday, November 4, 2026 | Dementia
Abstract INTRODUCTION Blood-based biomarkers, particularly phosphorylated tau 217 (p-tau217), can detect early Alzheimer’s disease (AD) neuropathological changes. Recent work has shown that p-tau217 is lower in individuals with stable cognition and higher...
by Clinical Neuropsychologist Online | Wednesday, November 4, 2026 | Dementia
Abstract INTRODUCTION Combining Alzheimer’s disease blood biomarkers may improve prediction of amyloid positivity (A+) compared with single biomarkers. METHODS Logistic regression models using plasma phosphorylated tau 217 (p-tau217), amyloid beta (Aβ) 42, and...
by Clinical Neuropsychologist Online | Wednesday, November 4, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 11, November 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | November 4, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Tuesday, November 3, 2026 | Dementia
Dementia, Ahead of Print. Psychotherapeutic interventions can support people with dementia. Family members often play a pivotal role in the therapeutic process but little is known about their experiences of therapy, how they perceive the impact on their relative, and...
by Clinical Neuropsychologist Online | Sunday, November 1, 2026 | Dementia
Abstract INTRODUCTION Sleep disturbances are common in older adults and linked to cognitive decline, but their association with functional abilities such as financial and health literacy is less understood. METHODS Participants without dementia from the Rush Memory...
